Vincent P.
Chief Commercial Officer
Sales & Marketing
CDBIO
Lithuania
Biography
Mr. Vincent P. Mihalik, also known as Vince, has been Chief Commercial Officer and Senior Vice President of Sales & Marketing at Amylin Pharmaceuticals Inc. since January 2009. Mr. Mihalik oversees marketing and sales for Amylin's two marketed products, BYETTA(R) (exenatide) injection and SYMLIN(R) (pramlintide acetate) injection, as well as the launch and commercialization of exenatide once weekly, Amylin's lead development compound. Mr. Mihalik has a combined 40 years of experience in the pharmaceutical and biomedical industries. He has more than 20 years of experience across multiple commercial roles, including global product development, sales and sales management, product launches and brand management. He has a successful track record in leadership at a number of companies focused on improving care for patients from 1990 to 2001. He served as Vice President and Global Brand Development Platform Leader of Diabetes Obesity & Endocrine at Eli Lilly and Company. since 2004, where he managed the second largest therapeutic area for it and was responsible for product development beyond Phase 2b to launch for lifecycle planning and commercialization. His career has focused on diabetes, with numerous leadership roles at leading pharmaceutical companies.
Research Interest
Bussiness Development
